BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 16496339)

  • 1. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Genes Immun; 2007 Apr; 8(3):181-92. PubMed ID: 17230195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.
    Neumann-Haefelin C; Timm J; Schmidt J; Kersting N; Fitzmaurice K; Oniangue-Ndza C; Kemper MN; Humphreys I; McKiernan S; Kelleher D; Lohmann V; Bowness P; Huzly D; Rosen HR; Kim AY; Lauer GM; Allen TM; Barnes E; Roggendorf M; Blum HE; Thimme R
    Hepatology; 2010 Jan; 51(1):54-62. PubMed ID: 20034048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.
    Komatsu H; Lauer G; Pybus OG; Ouchi K; Wong D; Ward S; Walker B; Klenerman P
    J Viral Hepat; 2006 Feb; 13(2):121-30. PubMed ID: 16436130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.
    Neumann-Haefelin C; Oniangue-Ndza C; Kuntzen T; Schmidt J; Nitschke K; Sidney J; Caillet-Saguy C; Binder M; Kersting N; Kemper MW; Power KA; Ingber S; Reyor LL; Hills-Evans K; Kim AY; Lauer GM; Lohmann V; Sette A; Henn MR; Bressanelli S; Thimme R; Allen TM
    Hepatology; 2011 Oct; 54(4):1157-66. PubMed ID: 22006856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
    Cheuk E; Chamberlain JW
    Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
    Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
    Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?
    Neumann-Haefelin C
    Curr Opin Rheumatol; 2013 Jul; 25(4):426-33. PubMed ID: 23656712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.